Literature DB >> 8029441

Designation and schematic structure of gangliosides and allied glycosphingolipids.

L Svennerholm1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8029441     DOI： 10.1016/S0079-6123(08)61935-4

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  33 in total

1.  Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth.

Authors:  Kazim A Sheikh
Journal:  Small GTPases       Date:  2011-07-01

2.  Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.

Authors:  Tonya J Webb; Xiangming Li; Robert L Giuntoli; Pablo H H Lopez; Christoph Heuser; Ronald L Schnaar; Moriya Tsuji; Christian Kurts; Mathias Oelke; Jonathan P Schneck
Journal:  Cancer Res       Date:  2012-05-30       Impact factor: 12.701

Review 3.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

4.  Sialylation regulates brain structure and function.

Authors:  Seung-Wan Yoo; Mary G Motari; Keiichiro Susuki; Jillian Prendergast; Andrea Mountney; Andres Hurtado; Ronald L Schnaar
Journal:  FASEB J       Date:  2015-04-06       Impact factor: 5.191

5.  Biosynthesis of the major brain gangliosides GD1a and GT1b.

Authors:  Elizabeth R Sturgill; Kazuhiro Aoki; Pablo H H Lopez; Daniel Colacurcio; Katarina Vajn; Ileana Lorenzini; Senka Majić; Won Ho Yang; Marija Heffer; Michael Tiemeyer; Jamey D Marth; Ronald L Schnaar
Journal:  Glycobiology       Date:  2012-06-26       Impact factor: 4.313

6.  Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.

Authors:  Tadahiro Kumagai; Takeshi Sato; Shunji Natsuka; Yukito Kobayashi; Dapeng Zhou; Tadashi Shinkai; Satoru Hayakawa; Kiyoshi Furukawa
Journal:  Glycoconj J       Date:  2010-11-06       Impact factor: 2.916

7.  Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.

Authors:  Baohan Pan; Susan E Fromholt; Ellen J Hess; Thomas O Crawford; John W Griffin; Kazim A Sheikh; Ronald L Schnaar
Journal:  Exp Neurol       Date:  2005-09       Impact factor: 5.330

8.  Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Authors:  Denggao Yao; Rhona McGonigal; Jennifer A Barrie; Joanna Cappell; Madeleine E Cunningham; Gavin R Meehan; Simon N Fewou; Julia M Edgar; Edward Rowan; Yuhsuke Ohmi; Keiko Furukawa; Koichi Furukawa; Peter J Brophy; Hugh J Willison
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

9.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis.

Authors:  Chien-Tsun Kuan; Jinli Chang; Jan-Eric Mansson; Jianjun Li; Charles Pegram; Pam Fredman; Roger E McLendon; Darell D Bigner
Journal:  BMC Dev Biol       Date:  2010-11-18       Impact factor: 1.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.